ESTABLISHMENT LABS HOLDINGS INC. — Form 8-K
Filed October 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 62/100
What the filing says
Establishment Labs amended its Master Supply Agreement with NuSil Technology LLC, effective January 1, 2027. The contract term was extended from December 31, 2026 to December 31, 2031 (5-year extension). Key changes include: exclusive silicone sourcing obligation for implant shells/gels, payment terms shifted to Net 30 EOM, addition of joint IP governance clause, and a last-time buy provision allowing up to [redacted] months of inventory upon NuSil's change of control. Multiple pricing and product specifications remain redacted.
Why this rating
Material supplier agreement extension secures critical input for medical device business; 5-year term provides supply certainty but exclusivity creates dependency. Redacted financials obscure full impact assessment relative to ~$975M market cap.
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.